ABL and MicroTest Separately Announce Contract Manufacturing Deals

ABL will carry out cGMP production of rhFSH for Trophogen, while Microtest will manufacture ImmusanT’s celiac disease vaccine.

U.K.’s Technology Strategy Board Awards £900K to Stem Cell Research Consortium

Cellzome-led consortium will characterize stem cells through protein fingerprints that predict behavior changes.

Sigma-Aldrich Snaps Up BioReliance for $350M

Deal for contract testing services provider is expected to close later in first quarter.

Nanohale Acquires Scil Technology’s Development, Formulation, and Analytics Assets

Firm maintains acquisition will allow transition from technology platform operation to specialty pharma company.

Pall to Take Over ForteBio for Protein Analysis Systems

Firm’s instruments boost Pall’s process monitoring and protein research offerings.

FDA Clears Hologic’s Automated Platform for Cervical Cancer Cervista HPV Assay

Cervista HTA system automates DNA extraction and detection procedures.

Renova to Develop Transgenic Rabbits for Pharming’s Recombinant FVIII Program

Maryland firm announced birth of rhFVII transgenic rabbits at Chinese subsidiary.

Novozymes Accesses MorphoSys’ Slonomics Platform for Industrial Biotech

Firm will use protein engineering technology to shorten enzyme discovery time.

Lonza Expands Small Molecule Manufacturing Facility in China

Nansha site now houses additional capacity for small-scale API production.

GE Healthcare, M+W to Bolster Biomanufacturing in Emerging Nations

Firms will help governments construct and run facilities to manufacture vaccines and biopharmaceuticals such as insulin.

Recently Featured

Scroll Up